ASND ▲ +0.1% - Ascendis Pharma A/S
$ASND - Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
16-OCT-2026 08:29 AM ET
Share this post
More filings for $ASND
ASND ▼ -0.0% - Ascendis Pharma A/SOct 6, 2026ASND ▲ +1.3% - Ascendis Pharma A/SSep 14, 2026ASND ▲ +1.3% - Ascendis Pharma A/SSep 14, 2026ASND ▼ -3.4% - Ascendis Pharma A/SSep 9, 2026ASND ▼ -0.2% - Ascendis Pharma A/SSep 8, 2026ASND ▲ +0.4% - Ascendis Pharma A/SAug 31, 2026
View full $ASND filing history →💬 Comments
Loading comments…
Leave a comment